Sekar Kathiresan Email

CEO, Founder . Verve Therapeutics

Current Roles

Employees:
332
Revenue:
$23.9M
About
Verve Therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. The company brings together human genetics analysis and gene editing ᅢᄁ¬ツᆲ¬タワ two of the biggest breakthroughs in 21st century biomedicine ᅢᄁ¬ツᆲ¬タワ to develop transformative therapies for coronary heart disease. Verve is developing medicines, administered once in life, to safely edit the genome of adults to permanently lower LDL cholesterol and triglyceride levels and thereby treat coronary heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, Verve is backed by a top-tier syndicate of investors, including GV (formerly Google Ventures), ARCH Venture Partners, F-Prime Capital, Biomatics Capital, Wellington Management, Casdin Capital, and Partners Innovation Fund. The company was recognized as a "2020 Best Places to Work" by the Boston Business Journal. Verve is headquartered in Cambridge, Massachusetts.
Verve Therapeutics Address
201 Brookline Avenue
Cambridge, MA
United States
Verve Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.